On October 25, Zencore Biologics Co., Ltd. (Zencore Biologics) officially signed a strategic cooperation agreement with Hangzhou Meisai Biomedical Technology Co Ltd. (Med-Immune Science). Zencore Biologics will engage in long-term, comprehensive strategic collaboration with Med-Immune Science, combining their expertise in the CDMO sector with Med-Immune Science 's capabilities in the field of innovative drug development.
Strategic Cooperation Signing Ceremony
Right 1 - Founder and General Manager of Meisai Bio, Hong Yuan
Left 1 - Executive Director of Zhengge Bio, Zhiyong Shen